Education
About Us
Working with TipRanks
Follow Us
MGV - AI Analysis
Top Page
Vanguard Mega Cap Value ETF (MGV)
Rating:72Outperform
Price Target:
$154.00
Positive Factors
Strong Top Holdings
Several key positions, such as Johnson & Johnson and AbbVie, have delivered strong year-to-date performance, boosting the ETF's returns.
Low Expense Ratio
The ETF has a very low expense ratio compared to industry averages, allowing investors to keep more of their gains.
Sector Diversification
The fund is spread across multiple sectors, including Financials, Health Care, and Industrials, reducing the risk of overexposure to one industry.
Negative Factors
High Geographic Concentration
The ETF is heavily focused on U.S. companies, limiting exposure to international markets and global diversification.
Underperforming Holdings
Some top holdings, such as UnitedHealth and Procter & Gamble, have lagged in year-to-date performance, dragging on overall returns.
Financial Sector Overweight
With over 26% of the portfolio allocated to Financials, the ETF is highly sensitive to fluctuations in this sector.
MGV vs. SPDR S&P 500 ETF (SPY)
AUM10.25B
RegionNorth America
Expense Ratio0.07%
Beta0.71
IssuerVanguard
Inception DateDec 17, 2007
Dividend Yield2.03%
Asset ClassEquity
Index TrackedCRSP US Mega Value
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume231,244
30 Day Avg. Volume281,460
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
156.76Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering124
MGV Summary
The Vanguard Mega Cap Value ETF (MGV) is designed to give investors access to large U.S. companies that are considered undervalued compared to their true worth. It focuses on 'value' stocks, which are often stable and financially strong. Some of its top holdings include well-known companies like JPMorgan Chase and Berkshire Hathaway. This ETF is a good option for investors looking to diversify their portfolio with established companies and potentially benefit from long-term growth. However, since it primarily invests in large-cap U.S. stocks, its performance can be affected by overall market trends and economic conditions.
How much will it cost me?The Vanguard Mega Cap Value ETF (MGV) has an expense ratio of 0.07%, which means you’ll pay $0.70 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down.
What would affect this ETF?The Vanguard Mega Cap Value ETF (MGV) could benefit from economic stability and rising interest rates, which often favor financial and value-oriented stocks like JPMorgan Chase and Berkshire Hathaway. Additionally, strong performance in sectors like healthcare and consumer defensive could provide resilience during economic uncertainty. However, potential risks include regulatory changes affecting financial and healthcare sectors, as well as broader market downturns that could impact large-cap stocks disproportionately.
MGV Top 10 Holdings
The Vanguard Mega Cap Value ETF (MGV) leans heavily into financials, with names like JPMorgan Chase driving steady performance despite some recent headwinds. Health care stocks, including Johnson & Johnson and AbbVie, are rising stars, buoyed by strong earnings and growth prospects. Meanwhile, consumer staples giant Procter & Gamble is lagging, weighed down by slowing growth and macroeconomic challenges. The fund’s U.S.-focused portfolio showcases a value-driven approach, with a tilt toward stability and resilience, though mixed results in sectors like consumer discretionary add a touch of unpredictability to the mix.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| JPMorgan Chase | 4.81% | $503.31M | $855.50B | 39.55% | 70 Outperform | |
| Berkshire Hathaway B | 3.79% | $396.71M | $1.03T | 5.62% | 69 Neutral | |
| Exxon Mobil | 2.67% | $278.93M | $487.54B | -0.51% | 79 Outperform | |
| Walmart | 2.51% | $262.49M | $806.69B | 23.10% | 75 Outperform | |
| Johnson & Johnson | 2.48% | $259.13M | $455.04B | 17.95% | 78 Outperform | |
| AbbVie | 2.27% | $237.35M | $385.18B | 7.12% | 59 Neutral | |
| Home Depot | 2.24% | $234.04M | $377.84B | -3.31% | 75 Outperform | |
| Procter & Gamble | 2.00% | $208.84M | $351.37B | -8.92% | 74 Outperform | |
| Bank of America | 1.91% | $199.56M | $395.90B | 27.99% | 70 Outperform | |
| UnitedHealth | 1.73% | $181.47M | $309.40B | -39.82% | 76 Outperform |
MGV Technical Analysis
Positive
―
Price Trends
136.51
Positive
133.57
Positive
129.58
Positive
Market Momentum
0.42
Positive
48.98
Neutral
20.83
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MGV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 137.82, equal to the 50-day MA of 136.51, and equal to the 200-day MA of 129.58, indicating a neutral trend. The MACD of 0.42 indicates Positive momentum. The RSI at 48.98 is Neutral, neither overbought nor oversold. The STOCH value of 20.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MGV.
MGV Peer Comparison
Comparison Results
Performance Comparison
MGV
Vanguard Mega Cap Value ETF
137.31
12.40
9.93%
VTV
Vanguard Value ETF
―
―
―
IWD
iShares Russell 1000 Value ETF
―
―
―
IVE
iShares S&P 500 Value ETF
―
―
―
SPYV
SPDR Portfolio S&P 500 Value ETF
―
―
―
VONV
Vanguard Russell 1000 Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents